-
Beijing Expands Medical Insurance Coverage to Include Anti-Aquaporin Antibody Testing and Advanced Heart Procedures
•
The Beijing Municipal Medical Insurance Bureau and the Beijing Municipal Human Resources and Social Security Bureau have issued a notification to include new medical service items such as anti-aquaporin antibody testing in the medical insurance coverage, with a focus on dynamically adjusting their prices. The update extends coverage to include…
-
Innovent Biologics Launches Phase I Clinical Trial for IBR822 Cell Injection Solution in Solid Tumors
•
Innovent Biologics (Hangzhou) Co., Ltd (HKG: 1801, OTCMKTS: IVBXF), a biopharmaceutical company based in China, has announced the successful initiation of a Phase I clinical trial for its proprietary IBR822 cell injection solution at Zhejiang Cancer Hospital. The trial, led by Professor Song Zhengbo from Zhejiang Cancer Hospital, is conducted…
-
Former Hainan Medical University President Li Jingquan Expelled for Serious Disciplinary Violations
•
Hainan’s disciplinary inspection committee has announced the expulsion of Li Jingquan, the former president of the First Affiliated Hospital of Hainan Medical University, from the Communist Party and public office due to serious violations of discipline and law. Li was found to have committed multiple infractions, including accepting gifts and…
-
Hygeia Healthcare Holdings Acquires Chang An Hospital in Deal Valued at RMB 1.66 Billion
•
Hygeia Healthcare Holdings Co., Ltd, a Shanghai-based medical investment and healthcare group, has announced the completion of an acquisition, securing a 100% stake in Chang An Hospital, a state-owned Class 3A general hospital. The transaction, which is reported to have already been finalized, involved a consideration of approximately RMB 1.66…
-
WeDoctor Partners with Shanghai Children’s Medical Center to Enhance Pediatric Care
•
WeDoctor Holdings Ltd, a subsidiary of Chinese internet conglomerate Tencent Corporate Venture Capital (HKG: 0700) that specializes in online medical services, has entered into a strategic partnership with Shanghai Children’s Medical Center. While financial details of the agreement were not disclosed, the collaboration aims to combine WeDoctor’s expertise in digitalization…
-
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
•
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome Editing Research, establishing a framework to regulate such activities and ensure their responsible development. The guidelines place a stringent prohibition on germline editing, which involves genetic modifications that could be passed down to future generations.…
-
Shineco Inc. Acquires 80% Stake in ‘Internet+Medical Care’ Platform Meitong Tech for USD 20 Million
•
Shineco Inc. (NASDAQ: SISI), a U.S.-based company, has signed an investment agreement with Beijing Dongfang Meitong Technology Co., Ltd, a China-headquartered “Internet+medical care” platform. Shineco is set to acquire an 80% stake in Meitong Tech for USD 20 million. Meitong Tech, a leading shared medical device company in China, offers…
-
China’s NHC Mandates Urban Hospitals to Aid County-Level Medical Institutions
•
The National Health Commission (NHC) has issued a notification aimed at further promoting the allocation of urban medical resources to county hospitals and grassroots medical institutions. The directive emphasizes that urban Class 3 hospitals should provide assistance to county hospitals, particularly those with underperforming metrics. The notice outlines several key…
-
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
•
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a strategic partnership with Baidu Health. This collaboration aims to focus on AI intelligent outpatient services, thereby strengthening the digital transformation of medical services. The hospital has demonstrated initial success with its AI intelligent outpatient system,…
-
Eli Lilly & Co. Expands Clinical Collaboration with Shanghai East Hospital in China
•
Eli Lilly & Co. (NYSE: LLY), a leading global pharmaceutical company, has announced an expansion of its clinical partnership with Shanghai East Hospital, a Class 3A general hospital in China. This strategic collaboration aims to address the increasing demand for clinical studies within the country. The two entities initially collaborated…
-
Beijing Sanbo Hospital and AGE Dr. Hospital Management Group Join Forces in Brain Disease Care
•
Beijing Sanbo Hospital Co., Ltd, a prominent healthcare provider in China, has entered into a strategic partnership with AGE Dr. Hospital Management Group (Boao Yiling), a leading hospital management group. The collaboration will focus on key areas such as department construction, talent development, technical collaboration, and joint scientific research initiatives.…
-
China’s NHC Mandates Enhanced Management and Accessibility of Midwifery Services
•
The National Health Commission (NHC) has issued a notification with the aim of enhancing the management of midwifery services, outlining a total of six requirements to improve accessibility and service quality. The first requirement is to strengthen the planning and layout of midwifery services, with the goal of promoting provincial…
-
Fosun Health and Adventist Medical Center Partner to Enhance GBA Medical Services
•
China-based Fosun Health Consumption Industry Group has entered into a strategic partnership with Hong Kong’s Adventist Medical Center, aiming to leverage their combined resources and expertise to enhance medical services in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Under the terms of the agreement, both organizations will intensify collaboration in…
-
Swire Pacific to Deepen Healthcare Investment Focus in China and Indonesia
•
Swire Pacific, a Hong Kong-based conglomerate, is gearing up to focus on healthcare investments in China and Indonesia, according to its 2023 annual report. This strategic shift follows a record year for the firm, which saw underlying profits reach HKD 36.2 billion (USD 4.63 billion). In March, Swire reached an…
-
Mabwell Bioscience Extends Research Partnership with Fudan University Cancer Center
•
Mabwell (Shanghai) Bioscience Co., Ltd., (SHA: 688062) has announced the renewal of its strategic research partnership with Fudan University Shanghai Cancer Center. The collaboration, initiated in July 2021, focuses on advancing research cooperation, nurturing talent, enhancing hospital management, and constructing robust platforms for scientific exchange. The partnership has seen significant…
-
Shaanxi Province Unveils Ambitious Three-Year Plan to Boost Traditional Chinese Medicine Industry
•
The provincial government of Shaanxi has unveiled the “Three Year Action Plan for Empowering Shaanxi Province with Traditional Chinese Medicine (TCM) (2024-2026),” with ambitions to position its TCM facilities among the nation’s leaders and to achieve a total industry output value of RMB 100 billion by 2026. The plan outlines…
-
China Anti-Cancer Association Forms Consortium for Standardizing Cancer Research Ethics Reviews
•
The medical ethics professional committee of the China Anti-Cancer Association (CACA) has announced the formation of the China Cancer Clinical Research Medical Ethics Review Mutual Recognition Consortium. This consortium aims to streamline and standardize the ethical review process for clinical research in cancer treatment across China. The founding members of…
-
Shaanxi Panlong Pharmaceutical Partners with Xi’an Medical University for Multifaceted Collaboration
•
Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864), a leading pharmaceutical company based in China, has announced the signing of a cooperation framework agreement with Xi’an Medical University. This strategic partnership will see the two entities leveraging their respective resources to collaborate across various fields. Under the agreement, Panlong Pharma…
-
Meizhong Jiahe Medical Debuts on Hong Kong Stock Exchange Below IPO Price
•
China-based Meizhong Jiahe Medical Science & Technology Development Co., Ltd has completed its initial public offering (IPO) on the Hong Kong Stock Exchange, with shares priced at HKD 14.28 per share. The stock opened trading at HKD 9.8 per share and, as of the noon close, had risen to HKD…
-
China’s Ministry of Education Launches Professional Guidelines for Healthcare Talent Training
•
The Ministry of Education (MoE) in China has issued a Notice outlining the “Professional Guidelines for Training Talent in the Healthcare Industry,” which includes the establishment of five new medical majors for universities to offer to Chinese students. The initiative, crafted by MoE experts, is designed to nurture talents in…
-
Hengrui Medicine-Backed Nanjing Tianyinshan Hospital Opens as Class 3A Oncology Specialist Center
•
Nanjing Tianyinshan Hospital, a private Class 3A oncology specialist hospital invested in by Hengrui Medicine (SHA: 600276), commenced operations on December 22. The hospital is headed by Professor Qin Shukui, a prominent figure in the field of oncology. Situated in the Nanjing Jiangning High Tech Zone, the hospital spans a…
-
Baidu Health and Chongqing’s Fifth People’s Hospital Collaborate on Integrated Medical Services
•
Baidu Health has entered into a partnership with the Fifth People’s Hospital of Chongqing, a Class 3A general hospital in China. The collaboration aims to combine the hospital’s disciplinary and location advantages with Baidu Health’s strengths in online diagnosis, treatment, digitalization, and artificial intelligence (AI) to establish an integrated online-offline…
-
Zeiss Group and China’s Healthcare Cloud Collaborate on Ophthalmic Services in China
•
Germany-based Zeiss Group, a leader in optical systems and optoelectronic product manufacturing, has entered into a partnership with China’s Healthcare Cloud, an online health services provider, during the recent China International Import Expo (CIIE) meeting. The collaboration aims to enhance ophthalmic services in China by leveraging the strengths of both…
-
Danaher Corporation Partners with CHEA to Boost Oncology Centers in Chinese Counties
•
US-based science and technology services giant Danaher Corporation (NYSE: DHR) has entered into a partnership with the hospital management unit of the China Health Economics Association (CHEA). The collaboration aims to promote the development of oncology prevention and control centers at the county hospital level in China, with no financial…
-
Zhejiang Boner Medical Secures Over RMB 800 Million in Pre-IPO Financing for Strategic Expansion
•
Zhejiang Boner Medical Investment Management Co., Ltd., known as Bang-er Orthopedics, a leading hospital investment operator focused on orthopedics and rehabilitation, has reportedly raised over RMB 800 million (USD 110 million) in a pre-IPO financing round. The round was led by C&D Emerging Industry Equity Investment, with participation from Sunshine…
-
Sun Yat-sen Memorial Hospital Partners with Siemens Healthineers on Metaverse Visualization Surgery
•
China’s Sun Yat-sen Memorial Hospital, affiliated with Sun Yat-sen University, has entered into a strategic partnership with Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) at the 6th China International Import Expo (CIIE) in Shanghai. The collaboration focuses on the science research, application, and translation of metaverse visualization surgery,…
-
Peking University Unveils National Standardized Pain Treatment Center in China
•
Peking University People’s Hospital has officially unveiled the plaque for the National Standardized Pain Treatment Center, marking a significant step in promoting high-quality pain medical resources across China. The center is designed to channel expertise and resources to grassroots levels through initiatives such as talent cultivation and clinical support, enhancing…
-
China’s Ministry of Health Tightens Organ Transplant Regulations with Expert Conference
•
Shi Bingyi, a distinguished Member of the National Committee of the CPPCC (Chinese People’s Political Consultative Conference) and Director of the Organ Transplantation Center of the People’s Liberation Army (PLA), has disclosed that China’s Ministry of Health has convened a panel of 70 experts to rigorously assess hospitals involved in…
